- Home
- Shop
- New Categories
- New Blog
- Contact Us
- Cart
- Login
- Register
Select the image to view it full size.
Product details
Catalog number HLL0751501301.1G
Price for HLL0751501301.1G
Size / count 1 g
Wang resins are the standard supports for the synthesis of peptide acids by solid phase synthesis using the Fmoc strategy. Fmoc protected amino acids are linked to Polystyrene-PHB (Wang resin, consisting of 1% crosslinked polystyrene functionalized with the TFA labile p-benzyloxybenzyl alcohol linker) . 50 - 95% TFA treatment generates free peptide acids. Low loaded Fmoc AA Wang resin - an ideal support for the synthesis of long or difficult peptides. Capacity: 0.2 - 0.35 mmol/g Enantiomeric purity*: > 99.5% Dipeptide content: < 0.5% *with exception of Cys and His Fmoc D-amino acids on request.
The catalog number for Fmoc-Ala Wang Resin LL is HLL0751501301.1G.
Fmoc-Ala Wang Resin LL is available in the following size(s): 1 g.
Fmoc-Ala Wang Resin LL is currently made to order / not held in immediate stock. Contact us for lead time.
Wang resins are the standard supports for the synthesis of peptide acids by solid phase synthesis using the Fmoc strategy. Fmoc protected amino acids are linked to Polystyrene-PHB (Wang resin, consisting of 1% crosslinked polystyrene functionalized with the TFA labile p-benzyloxybenzyl alcohol linke
Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.
The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.
As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.
